Antipsychotic drugs: pro-cancer or anti-cancer? A systematic review.
about
DNA Damage and Repair in Schizophrenia and Autism: Implications for Cancer Comorbidity and BeyondCancer in patients with schizophrenia: What is the next step?Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review.Analysis of schizophrenia and hepatocellular carcinoma genetic network with corresponding modularity and pathways: novel insights to the immune systemMedication Exposures and Subsequent Development of Ewing Sarcoma: A Review of FDA Adverse Event Reports.Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.Repurposing antipsychotics as glioblastoma therapeutics: Potentials and challengesRelationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review.Prolactin and breast cancer: The need to avoid undertreatment of serious psychiatric illnesses in breast cancer patients: A review.Penfluridol induces endoplasmic reticulum stress leading to autophagy in pancreatic cancer.Synthesis and biological evaluation of novel propargylquinobenzothiazines and their derivatives as potential antiproliferative, anti-inflammatory, and anticancer agents.Ziprasidone induces cytotoxicity and genotoxicity in human peripheral lymphocytes.New fluphenazine analogue with antimutagenic and anti-multidrug resistance activity-degradation profile and stability-indicating method.Potential antitumor mechanisms of phenothiazine drugs.Association of Schizophrenia With the Risk of Breast Cancer Incidence: A Meta-analysis.Glioma in Schizophrenia: Is the Risk Higher or Lower?
P2860
Q26743371-FCA20280-931C-4FFD-9BFD-AF2259E686B6Q30249107-AB806759-2005-4FDA-8414-94DFE0DF7885Q33878816-889061DD-538D-412B-A2A1-3B534FFFB315Q35101267-7A0F43D1-31E5-4644-95DD-3B0D47181691Q35630645-7A140B10-4B6C-4EDA-8A35-C6CA69DD6C91Q35754726-3913759E-D0EB-42C4-9790-B3AAD8B8E973Q36524716-25A516B3-1F27-4D5D-B1D1-83D1EFF7C8F5Q38538492-1FA8910D-F7DD-45FE-9555-57ACC0E940F0Q38604789-925AF58F-493C-4A24-8648-796F33C1160CQ38700179-FF8EB736-F755-4089-87DB-FC4E0927F0B4Q38758568-3D5906B8-E8D8-4C54-8FEE-52241F118220Q39148095-D861002E-35C0-47F2-ADC8-C67A18B4D871Q42370387-78577AAC-5901-4490-B9D9-405100DF47EDQ43795724-13C666A9-9AC5-4E90-A7DA-72292DAE9DCAQ53439170-B0ECC543-E3CF-4105-83C0-56F333E876C0Q58767549-4A802C67-6D63-4733-9B3B-3CDC69A6ECCD
P2860
Antipsychotic drugs: pro-cancer or anti-cancer? A systematic review.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Antipsychotic drugs: pro-cancer or anti-cancer? A systematic review.
@en
type
label
Antipsychotic drugs: pro-cancer or anti-cancer? A systematic review.
@en
prefLabel
Antipsychotic drugs: pro-cancer or anti-cancer? A systematic review.
@en
P2093
P50
P1433
P1476
Antipsychotic drugs: pro-cancer or anti-cancer? A systematic review
@en
P2093
P356
10.1016/J.MEHY.2012.03.026
P577
2012-04-28T00:00:00Z